Jubilant Pharmova has informed that in terms of Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company enclosed disclosure of Related Party Transactions on a consolidated basis, in the format specified in the accounting standards for the Financial Year ended March 31, 2021.
The above information is a part of company’s filings submitted to BSE.